List of insiders holdings for Denali Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | FMR LLC See Remark 1 | 2024-11-12 09:55:15 | 10,141,901 0 | 10,141,901 | Form 13G |
| 2 | NELSEN ROBERT Director | 2021-06-04 18:35:30 | 18,654 9,668,749 | 9,687,403 | Form 4 |
| 3 | BIOGEN INC. Biogen MA Inc. 10% Owner | 2024-11-07 16:48:26 | 7,155,243 0 | 7,155,243 | Form 13G |
| 4 | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 2024-02-13 16:27:05 | 5,750,882 0 | 5,750,882 | Form 13G |
| 5 | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 2024-02-13 16:27:05 | 5,750,882 0 | 5,750,882 | Form 13G |
| 6 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 2025-06-05 17:02:52 | 0 3,479,348 | 3,479,348 | Form 4 |
| 7 | Watts Ryan J. President and CEO | 2025-07-11 17:13:23 | 896,249 2,202,604 | 3,098,853 | Form 4 |
| 8 | Flagship Ventures Fund V L.P. AFEYAN NOUBAR Flagship Ventures Fund V General Partner LLC 10% Owner | 2021-02-16 17:08:00 | 2,730,263 0 | 2,730,263 | Form 13G |
| 9 | Tessier-Lavigne Marc Director | 2025-06-05 16:23:08 | 1,904,687 236,869 | 2,141,556 | Form 4 |
| 10 | FIL Ltd See Remark 1 | 2017-12-14 15:20:57 | 1,914,833 1,379 | 1,916,212 | Form 4 |
| 11 | Krognes Steve E. Director | 2025-06-05 16:29:16 | 49,905 781,797 | 831,702 | Form 4 |
| 12 | Schuth Alexander O. COFO and Secretary | 2025-01-08 20:25:44 | 244,308 523,749 | 768,057 | Form 4 |
| 13 | Ho Carole Chief Medical Officer | 2025-01-08 20:26:37 | 175,673 208,219 | 383,892 | Form 4 |
| 14 | FLATLEY JAY T Director | 2025-06-05 16:33:18 | 34,331 336,313 | 370,644 | Form 4 |
| 15 | SATO VICKI L Director | 2025-01-03 16:13:51 | 107,976 0 | 107,976 | Form 4 |
| 16 | Schenkein David P Director | 2025-06-05 16:26:51 | 33,368 57,464 | 90,832 | Form 4 |
| 17 | Klein Peter S Director | 2025-06-05 16:31:24 | 45,644 0 | 45,644 | Form 4 |
| 18 | Cook Jennifer E. Director | 2025-06-05 16:34:17 | 44,186 0 | 44,186 | Form 4 |
| 19 | Thornberry Nancy Director | 2025-06-05 16:25:53 | 42,828 0 | 42,828 | Form 4 |
| 20 | Cole Douglas G. Director | 2023-06-05 18:01:14 | 39,213 0 | 39,213 | Form 4 |
| 21 | Harris Erik Director | 2024-06-04 18:27:58 | 34,953 0 | 34,953 | Form 4 |
| 22 | ARCH Venture Fund VIII L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH 10% Owner | 2022-02-08 15:04:10 | 0 0 | 0 | Form 13G |